Reuters logo
5 years ago
BRIEF-Peregrine Pharma drops in premarket after discrepancies discovered in bavituximab trial data
September 24, 2012 / 12:06 PM / 5 years ago

BRIEF-Peregrine Pharma drops in premarket after discrepancies discovered in bavituximab trial data

1 Min Read

NEW YORK, Sept 24 (Reuters) - Peregrine Pharmaceuticals Inc : * Pharma drops 71.2 percent to $1.55 in premarket after discrepancies discovered in bavituximab trial data

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below